EMARegulatory
EMA recommends restricting use of Tecovirimat SIGA
Summary
EMA’s committee for human medicines, CHMP, has recommended that Tecovirimat SIGA should no longer be used for the treatment of mpox. This recommendation does not affect the…
EMA’s committee for human medicines, CHMP, has recommended that Tecovirimat SIGA should no longer be used for the treatment of mpox. This recommendation does not affect the…